scholarly journals Cutaneous T cell lymphoma and classic Hodgkin lymphoma of the B cell type within a single lymph node: composite lymphoma

2004 ◽  
Vol 57 (3) ◽  
pp. 329-331 ◽  
Author(s):  
M Steinhoff
2009 ◽  
Vol 17 (1) ◽  
pp. 72-76 ◽  
Author(s):  
Gabriela Gualco ◽  
Lucimara Chioato ◽  
Anke Van Den Berg ◽  
Lawrence M. Weiss ◽  
Carlos E. Bacchi

Blood ◽  
1983 ◽  
Vol 62 (6) ◽  
pp. 1176-1181 ◽  
Author(s):  
K Sheibani ◽  
SJ Forman ◽  
CD Winberg ◽  
H Rappaport

Abstract Although rare cases of chronic lymphocytic leukemia (CLL) of the T-cell type have been reported, CLL is more commonly found to be a neoplastic lymphoproliferative disease of B-cell origin. In this article, we describe a patient with long-standing CLL that was immunologically shown to be of the B-cell type, who, during the course of his disease, developed cutaneous T-cell lymphoma (CTCL), which was shown to be of the helper/inducer subtype. The neoplastic lymphoid cells in the skin infiltrate differed morphologically and immunologically from those in the peripheral blood. The occurrence of CTCL during this patient's clinical course represents a second neoplasm arising from a different cell line, rather than a tissue manifestation of the patient's CLL. To our knowledge, this is the first report in which the occurrence of CTCL is documented in a patient with immunologically known B-cell CLL. In addition to establishing the presence of B-cell CLL and CTCL of the helper/inducer T-cell type in the same patient, this case report demonstrates the usefulness and necessity of evaluating lymphoproliferative disorders by means of a multidisciplinary approach.


Blood ◽  
1983 ◽  
Vol 62 (6) ◽  
pp. 1176-1181
Author(s):  
K Sheibani ◽  
SJ Forman ◽  
CD Winberg ◽  
H Rappaport

Although rare cases of chronic lymphocytic leukemia (CLL) of the T-cell type have been reported, CLL is more commonly found to be a neoplastic lymphoproliferative disease of B-cell origin. In this article, we describe a patient with long-standing CLL that was immunologically shown to be of the B-cell type, who, during the course of his disease, developed cutaneous T-cell lymphoma (CTCL), which was shown to be of the helper/inducer subtype. The neoplastic lymphoid cells in the skin infiltrate differed morphologically and immunologically from those in the peripheral blood. The occurrence of CTCL during this patient's clinical course represents a second neoplasm arising from a different cell line, rather than a tissue manifestation of the patient's CLL. To our knowledge, this is the first report in which the occurrence of CTCL is documented in a patient with immunologically known B-cell CLL. In addition to establishing the presence of B-cell CLL and CTCL of the helper/inducer T-cell type in the same patient, this case report demonstrates the usefulness and necessity of evaluating lymphoproliferative disorders by means of a multidisciplinary approach.


2020 ◽  
Vol 70 (10) ◽  
pp. 804-811
Author(s):  
Emiko Takahashi ◽  
Takashi Tsuchida ◽  
Satoshi Baba ◽  
Toyonori Tsuzuki ◽  
Takatoshi Shimauchi ◽  
...  

2001 ◽  
pp. 64-65
Author(s):  
M. Mori ◽  
N. Pimpinelli ◽  
M. Santucci

2018 ◽  
Vol 2018 ◽  
pp. 1-4
Author(s):  
Shin Nagai ◽  
Junji Hiraga ◽  
Noriyuki Suzuki ◽  
Naruko Suzuki ◽  
Yusuke Takagi ◽  
...  

We report a rare case of composite lymphoma comprising extranodal NK/T-cell lymphoma, nasal type, (ENKL) and diffuse large B-cell lymphoma (DLBCL) in a 70-year-old man complaining of fatigue. Computed tomography showed multiple consolidations in both lungs, and ENKL was diagnosed from transbronchial lung biopsy. Positron emission tomography also detected abnormal uptake in the stomach, and DLBCL was diagnosed from subsequent gastroscopy. Two courses of chemotherapy including rituximab achieved reduction in DLBCL, but ENKL proved resistant to this treatment and progressed. Concomitant ENKL and DLBCL have not been previously described among reports of composite lymphomas.


2020 ◽  
Vol 154 (Supplement_1) ◽  
pp. S107-S107
Author(s):  
E Ozluk ◽  
E Wei

Abstract Introduction/Objective Growth patterns of nodular lymphocyte predominant Hogdkin lymphoma (NLPHL) has been further described by Fan et all. Pattern E is T cell/histiocyte rich large B-cell lymphoma-like and is quite rare. The treatment usually may follow large B cell lymphoma protocol instead of Hodgkin lymphoma regimen. Methods Here we report a patient with NLPHL pattern E. Patient was a 25 years-old African American man who initially presented with generalized lymphadenopathy. Results Biopsy of the axillary lymph node revealed effaced lymph node architecture by a malignant neoplasm in a diffuse and vaguely nodular pattern. In the background of a diffuse infiltrate, there were small to medium sized lymphocytes, numerous atypical large cells with irregular, basophilic nucleoli, and variable cytoplasm. The large cells focally sheeted out. Many histiocytes were also seen in the background. The large atypical cells were positive for CD20, BOB-1, OCT2, BCL-2 (focally), BCL-6, PAX5, and MUM-1, and IgD, whereas negative for BCL-1, CD10, CD15, CD30. CD2, CD3, CD4, CD5, CD7, CD8 highlighted numerous T cells with mild cytological atypia, forming rosettes around the large atypical cells. T cells were negative for ALK-1, CD1a, TdT with increased Ki-67 proliferation index around 35%. Although the surrounding T cells appear atypical in morphology, flow cytometric analysis showed predominantly reactive T-cells with no loss of T-cell associated antigens. PCR analysis showed a producible peak in a single IgH reaction. However, the fragment size of the peak observed did not meet the criteria. T-cell gene rearrangement by TCR gamma and TCR beta PCR was negative for monoclonal T-cells. BCL-1, BCL-2, and BCL-6 FISH panel were negative for gene rearrangements. Based on these findings the diagnosis was made at stage IV. Patient started treatment with R-CHOP therapy with subsequent relapse. Patient has been placed on RICE chemotherapy with partial response. Conclusion NLPHL Pattern E type should be differentiated from classical Hodgkin lymphoma, diffuse large B-cell lymphoma and peripheral T cell lymphoma because the treatment greatly differs from those with higher stage and tendency for recurrence. It is the pathologist role to lead the clinician and render a correct histopathologic diagnosis.


1994 ◽  
Vol 31 (5) ◽  
pp. 724-731 ◽  
Author(s):  
Florent Grange ◽  
Marie-Françoise Avril ◽  
Eric Esteve ◽  
Pascal Joly ◽  
Jacques Bosq ◽  
...  

2006 ◽  
Vol 45 (9) ◽  
pp. 641-647 ◽  
Author(s):  
Taku Inokuchi ◽  
Mayumi Shincho ◽  
Yuji Moriwaki ◽  
Tsuneyoshi Ka ◽  
Sumio Takahashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document